<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE HTML>
<html xml:lang="en" xmlns="http://www.w3.org/1999/xhtml" lang="en">
  <head>
    <meta http-equiv="Content-Type" content="text/html;charset=utf-8"/>
    <title>RECOMMENDATIONS.CELIDA.CODEX.NETZWERK-UNIVERSITAETSMEDIZIN.DE\Artifacts Summary - FHIR v5.0.0</title>

    <meta name="viewport" content="width=device-width, initial-scale=1.0"/>
    <meta name="author" content="http://hl7.org/fhir"/>

    <link rel="stylesheet" href="fhir.css"/>

      <!-- Bootstrap core CSS -->
    <link rel="stylesheet" href="assets/css/bootstrap-fhir.css"/>

      <!-- Project extras -->
    <link rel="stylesheet" href="assets/css/project.css"/>
    <link rel="stylesheet" href="assets/css/pygments-manni.css"/>
    <link rel="stylesheet" href="assets/css/jquery-ui.css"/>
  	<link rel="stylesheet" href="assets/css/prism.css"/>
      <!-- Placeholder for child template CSS declarations -->
  <!-- Placeholder for child template CSS declarations -->
<link rel="stylesheet" href="assets/css/colors.css"/>
<link rel="stylesheet" href="assets/css/celida.css"/>


    <script src="assets/js/fhir-table-scripts.js" type="text/javascript"> </script>

      <!-- HTML5 shim and Respond.js IE8 support of HTML5 elements and media queries -->
      <!-- [if lt IE 9]>
    <script src="assets/js/html5shiv.js"></script>
    <script src="assets/js/respond.min.js"></script>
    <![endif] -->

      <!-- Favicons -->
    <link sizes="144x144" rel="apple-touch-icon-precomposed" href="assets/ico/apple-touch-icon-144-precomposed.png"/>
    <link sizes="114x114" rel="apple-touch-icon-precomposed" href="assets/ico/apple-touch-icon-114-precomposed.png"/>
    <link sizes="72x72" rel="apple-touch-icon-precomposed" href="assets/ico/apple-touch-icon-72-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" href="assets/ico/apple-touch-icon-57-precomposed.png"/>
    <link rel="shortcut icon" href="assets/ico/favicon.png"/>
  </head>
  <body onload="document.body.style.opacity='1'">

	  <script src="assets/js/prism.js"></script>

    <style type="text/css">h2{--heading-prefix:"4"}
    h3,h4,h5,h6{--heading-prefix:"4.0"}</style>
    <div id="segment-header" class="segment">    <!-- segment-header -->
      <div class="container">    <!-- container -->
          <!-- Left logo - typically the publisher's logo - project or affiliate -->
<div id="project-nav">
  <a no-external="true" id="project-logo" href="https://www.github.com/CODEX-CELIDA/">
    <img src="assets/images/logo_celida.png" alt="Project home" height="71"/>
  </a>
</div>

  <!-- Right logo - for example the FHIR logo -->
  <!-- Make sure you have authorization to use the FHIR logo -->
<div id="family-nav">
  <a no-external="true" id="family-logo" href="https://www.netzwerk-universitaetsmedizin.de">
    <img src="assets/images/logo_num.svg" alt="FHIR website" height="70"/>
  </a>
</div>


        <div id="ig-status">
          <p><span style="font-size:12pt;font-weight:bold">CODEX+ CELIDA Recommendations</span><br/>1.5.2 - ci-build</p>
        </div>
      </div>   <!-- /container -->
    </div>    <!-- /segment-header -->

    <div id="segment-navbar" class="segment">    <!-- segment-navbar -->
      <div id="stripe"> </div>
      <div class="container">    <!-- container -->
          <!-- HEADER CONTENT -->

        <nav class="navbar navbar-inverse">
            <!-- status-bar -->
          <div class="container">
            <button data-target=".navbar-inverse-collapse" data-toggle="collapse" type="button" class="navbar-toggle">
              <span class="icon-bar"> </span>
              <span class="icon-bar"> </span>
              <span class="icon-bar"> </span>
            </button>
            <a href="http://hl7.org/fhir/R5/index.html" class="navbar-brand hidden">FHIR</a>
            <div class="nav-collapse collapse navbar-inverse-collapse">
                <!-- menu.xml -->

<ul class="nav navbar-nav">
  <li>
    <a href="index.html">Home</a>
  </li>
  <li>
    <a href="artifacts.html">Artifacts</a>
  </li>
  <li>
    <a href="downloads.html">Downloads</a>
  </li>
  <li>
    <a href="changelog.html">Change Log</a>
  </li>
</ul>
            </div>    <!-- /.nav-collapse -->
          </div>    <!-- /.container -->
        </nav>    <!-- /.navbar -->
        <!-- /HEADER CONTENT -->
      </div>    <!-- /container -->
    </div>    <!-- /segment-navbar -->
      <!-- status-bar -->

    <div id="segment-breadcrumb" class="segment">    <!-- segment-breadcrumb -->
      <div class="container">    <!-- container -->
        <ul class="breadcrumb">
          <li><a href="toc.html"><b>Table of Contents</b></a></li><li><b>Artifacts Summary</b></li>

        </ul>
      </div>    <!-- /container -->
    </div>    <!-- /segment-breadcrumb -->

    <a name="top"> </a>
    <div id="segment-content" class="segment">    <!-- segment-content -->
      <div class="container">    <!-- container -->
        <div class="row">
          <div class="inner-wrapper">

<style type="text/css">
h2:before{color:silver;counter-increment:section;content:var(--heading-prefix) " ";}
h3:before{color:silver;counter-increment:sub-section;content:var(--heading-prefix) "." counter(sub-section) " ";}
h4:before{color:silver;counter-increment:composite;content:var(--heading-prefix) "." counter(sub-section) "." counter(composite) " ";}
h5:before{color:silver;counter-increment:detail;content:var(--heading-prefix) "." counter(sub-section) "." counter(composite) "." counter(detail) " ";}
h6:before{color:silver;counter-increment:more-detail;content:var(--heading-prefix) "." counter(sub-section) "." counter(composite) "." counter(detail) "." counter(more-detail)" ";}
</style>
<div class="col-12">
    <!-- ReleaseHeader --><p id="publish-box">CODEX+ CELIDA Recommendations - Local Development build (v1.5.2) built by the FHIR (HL7&reg; FHIR&reg; Standard) Build Tools. See the <a href="https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/history.html">Directory of published versions</a></p>  <!-- EndReleaseHeader -->
  <h2>Artifacts Summary</h2>
  
  
  
    <!-- DO NOT EDIT THIS FILE - It is generated and any changes made will be overwritten --><div xmlns:html="http://www.w3.org/1999/xhtml" xmlns:f="http://hl7.org/fhir" class="markdown-toc">
   <p>Contents:</p>
   <ul>
      <li>
         <a href="#1">Knowledge Artifacts: Activity Definitions</a>
      </li>
      <li>
         <a href="#2">Knowledge Artifacts: Plan Definitions</a>
      </li>
      <li>
         <a href="#3">Terminology: Code Systems</a>
      </li>
      <li>
         <a href="#4">Other</a>
      </li>
   </ul>
</div>
<div xmlns:html="http://www.w3.org/1999/xhtml" xmlns:f="http://hl7.org/fhir">
   <p>This page provides a list of the FHIR artifacts defined as part of this implementation guide.</p>
   <a name="1"> </a>
   <h3>Knowledge Artifacts: Activity Definitions </h3>
   <p>
    <p>These define activities that can be performed as part of content in this implementation guide.</p>
</p>
   <p>
      <table class="grid">
         <col style="width:20%"/>
         <tbody>
            <tr>
               <td style="column-width:30%">
                  <a href="ActivityDefinition-PronePositioning.html" title="ActivityDefinition/PronePositioning">Abdominal Positioning</a>
               </td>
               <td>
<p>In ARDS and a PaO2/FiO2 &lt; 150 mmHg, abdominal positioning should be consistently performed, with an abdominal positioning interval of at least 16 hours.</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="ActivityDefinition-ProphylacticAnticoagulationWCertoparin.html" title="ActivityDefinition/ProphylacticAnticoagulationWCertoparin">Antithrombotic prophylaxis with Certoparin</a>
               </td>
               <td>
<p>Antithrombotic prophylaxis with Certoparin in hospitalised COVID-19 patients (in absence of contraindications for LWMH)</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="ActivityDefinition-ProphylacticAnticoagulationWDalteparin.html" title="ActivityDefinition/ProphylacticAnticoagulationWDalteparin">Antithrombotic prophylaxis with Dalteparin</a>
               </td>
               <td>
<p>Antithrombotic prophylaxis with Dalteparin in hospitalised COVID-19 patients (in absence of contraindications for LWMH)</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="ActivityDefinition-ProphylacticAnticoagulationWEnoxaparin.html" title="ActivityDefinition/ProphylacticAnticoagulationWEnoxaparin">Antithrombotic prophylaxis with Enoxaparin</a>
               </td>
               <td>
<p>Antithrombotic prophylaxis with Enoxaparin in hospitalised COVID-19 patients (in absence of contraindications for LWMH)</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="ActivityDefinition-AntithromboticProphylaxisFondaparinuxSubcutaneous.html" title="ActivityDefinition/AntithromboticProphylaxisFondaparinuxSubcutaneous">Antithrombotic prophylaxis with Fondaparinux</a>
               </td>
               <td>
<p>Antithrombotic prophylaxis with Fondaparinux in hospitalised COVID-19 patients (when contraindications for LWMH exist)</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="ActivityDefinition-ProphylacticAnticoagulationWNadroparin.html" title="ActivityDefinition/ProphylacticAnticoagulationWNadroparin">Antithrombotic prophylaxis with Nadroparin</a>
               </td>
               <td>
<p>Antithrombotic prophylaxis with Nadroparin in hospitalised COVID-19 patients (in absence of contraindications for LWMH)</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="ActivityDefinition-ProphylacticAnticoagulationWTinzaparin.html" title="ActivityDefinition/ProphylacticAnticoagulationWTinzaparin">Antithrombotic prophylaxis with Tinzaparin</a>
               </td>
               <td>
<p>Antithrombotic prophylaxis with Tinzaparin in hospitalised COVID-19 patients</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="ActivityDefinition-NoTherapeuticAnticoagulationFondaparinux.html" title="ActivityDefinition/NoTherapeuticAnticoagulationFondaparinux">NO Therapeutic Anticoagulation Treatment with Fondaparinux</a>
               </td>
               <td>
<p>No Therapeutic Anticoagulation Treatment with Fondaparinux for non-intensive care hospitalised COVID-19 patients patients with no specific indications (i.e., pulmonary embolism)</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="ActivityDefinition-NoTherapeuticAnticoagulationWArgatra.html" title="ActivityDefinition/NoTherapeuticAnticoagulationWArgatra">No Therapeutic Anticoagulation Treatment with Argatroban</a>
               </td>
               <td>
<p>No Therapeutic Anticoagulation Treatment with Argatroban for non-intensive care hospitalised COVID-19 patients patients with no specific indications (i.e., pulmonary embolism)</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="ActivityDefinition-NoTherapeuticAnticoagulationWCertoparin.html" title="ActivityDefinition/NoTherapeuticAnticoagulationWCertoparin">No Therapeutic Anticoagulation Treatment with Certoparin</a>
               </td>
               <td>
<p>No Therapeutic Anticoagulation Treatment with Certoparin for non-intensive care hospitalised COVID-19 patients patients with no specific indications (i.e., pulmonary embolism)</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="ActivityDefinition-NoTherapeuticAnticoagulationWDalteparin1xd.html" title="ActivityDefinition/NoTherapeuticAnticoagulationWDalteparin1xd">No Therapeutic Anticoagulation Treatment with Dalteparin</a>
               </td>
               <td>
<p>No Therapeutic Anticoagulation Treatment with Dalteparin for non-intensive care hospitalised COVID-19 patients patients with no specific indications (i.e., pulmonary embolism)</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="ActivityDefinition-NoTherapeuticAnticoagulationWDalteparin2xd.html" title="ActivityDefinition/NoTherapeuticAnticoagulationWDalteparin2xd">No Therapeutic Anticoagulation Treatment with Dalteparin</a>
               </td>
               <td>
<p>No Therapeutic Anticoagulation Treatment with Dalteparin for non-intensive care hospitalised COVID-19 patients patients with no specific indications (i.e., pulmonary embolism)</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="ActivityDefinition-NoTherapeuticAnticoagulationWDalteparinTable.html" title="ActivityDefinition/NoTherapeuticAnticoagulationWDalteparinTable">No Therapeutic Anticoagulation Treatment with Dalteparin</a>
               </td>
               <td>
<p>No Therapeutic Anticoagulation Treatment with Dalteparin for non-intensive care hospitalised COVID-19 patients patients with no specific indications (i.e., pulmonary embolism)</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="ActivityDefinition-NoTherapeuticAnticoagulationWEnoxaparin1xd.html" title="ActivityDefinition/NoTherapeuticAnticoagulationWEnoxaparin1xd">No Therapeutic Anticoagulation Treatment with Enoxaparin</a>
               </td>
               <td>
<p>No Therapeutic Anticoagulation Treatment with Enoxaparin for non-intensive care hospitalised COVID-19 patients patients with no specific indications (i.e., pulmonary embolism)</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="ActivityDefinition-NoTherapeuticAnticoagulationWEnoxaparin2xd.html" title="ActivityDefinition/NoTherapeuticAnticoagulationWEnoxaparin2xd">No Therapeutic Anticoagulation Treatment with Enoxaparin</a>
               </td>
               <td>
<p>No Therapeutic Anticoagulation Treatment with Enoxaparin for non-intensive care hospitalised COVID-19 patients patients with no specific indications (i.e., pulmonary embolism)</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="ActivityDefinition-NoTherapeuticAnticoagulationWNadroparin.html" title="ActivityDefinition/NoTherapeuticAnticoagulationWNadroparin">No Therapeutic Anticoagulation Treatment with Nadroparin</a>
               </td>
               <td>
<p>No Therapeutic Anticoagulation Treatment with Nadroparin for non-intensive care hospitalised COVID-19 patients patients with no specific indications (i.e., pulmonary embolism)</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="ActivityDefinition-NoTherapeuticAnticoagulationWTinzaparin.html" title="ActivityDefinition/NoTherapeuticAnticoagulationWTinzaparin">No Therapeutic Anticoagulation Treatment with Tinzaparin</a>
               </td>
               <td>
<p>No Therapeutic Anticoagulation Treatment with Tinzaparin for non-intensive care hospitalised COVID-19 patients patients with no specific indications (i.e., pulmonary embolism)</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="ActivityDefinition-NoTherapeuticAnticoagulationWUFH.html" title="ActivityDefinition/NoTherapeuticAnticoagulationWUFH">No Therapeutic Anticoagulation Treatment with UFH</a>
               </td>
               <td>
<p>No Therapeutic Anticoagulation Treatment with UFH for non-intensive care hospitalised COVID-19 patients patients with no specific indications (i.e., pulmonary embolism)</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="ActivityDefinition-ProphylacticAnticoagulationWHeparinSC.html" title="ActivityDefinition/ProphylacticAnticoagulationWHeparinSC">Prophylactic Anticoagulation Treatment with UFH subcutaneous</a>
               </td>
               <td>
<p>Prophylactic Treatment with UFH subcutaneous for non-intensive care hospitalised COVID-19 patients</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="ActivityDefinition-TherapeuticAnticoagulationUFH.html" title="ActivityDefinition/TherapeuticAnticoagulationUFH">Therapeutic Anticoagulation Treatment UFH</a>
               </td>
               <td>
<p>Therapeutic Anticoagulation Treatment (UFH) for non-intensive care hospitalised COVID-19 patients patients with high risk (D-Dimer &gt;= 2mg/l)</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="ActivityDefinition-TherapeuticAnticoagulationWArgatra.html" title="ActivityDefinition/TherapeuticAnticoagulationWArgatra">Therapeutic Anticoagulation Treatment with Argatroban</a>
               </td>
               <td>
<p>Therapeutic Anticoagulation Treatment with Argatroban for non-intensive care hospitalised COVID-19 patients patients with no specific indications (i.e., pulmonary embolism)</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="ActivityDefinition-TherapeuticAnticoagulationNMHCertoparin.html" title="ActivityDefinition/TherapeuticAnticoagulationNMHCertoparin">Therapeutic Anticoagulation Treatment with Certoparin</a>
               </td>
               <td>
<p>Therapeutic Anticoagulation Treatment (NMH) for non-intensive care hospitalised COVID-19 patients patients with high risk (D-Dimer &gt;= 2mg/l) with Certoparin</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="ActivityDefinition-TherapeuticAnticoagulationNMHDalteparin1xd.html" title="ActivityDefinition/TherapeuticAnticoagulationNMHDalteparin1xd">Therapeutic Anticoagulation Treatment with Dalteparin</a>
               </td>
               <td>
<p>Therapeutic Anticoagulation Treatment (NMH) for non-intensive care hospitalised COVID-19 patients patients with high risk (D-Dimer &gt;= 2mg/l) with Dalteparin</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="ActivityDefinition-TherapeuticAnticoagulationNMHDalteparin2xd.html" title="ActivityDefinition/TherapeuticAnticoagulationNMHDalteparin2xd">Therapeutic Anticoagulation Treatment with Dalteparin</a>
               </td>
               <td>
<p>Therapeutic Anticoagulation Treatment (NMH) for non-intensive care hospitalised COVID-19 patients patients with high risk (D-Dimer &gt;= 2mg/l) with Dalteparin</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="ActivityDefinition-TherapeuticAnticoagulationNMHDalteparinTable.html" title="ActivityDefinition/TherapeuticAnticoagulationNMHDalteparinTable">Therapeutic Anticoagulation Treatment with Dalteparin</a>
               </td>
               <td>
<p>Therapeutic Anticoagulation Treatment (NMH) for non-intensive care hospitalised COVID-19 patients patients with high risk (D-Dimer &gt;= 2mg/l) with Dalteparin</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="ActivityDefinition-TherapeuticAnticoagulationNMHEnoxaparin1xd.html" title="ActivityDefinition/TherapeuticAnticoagulationNMHEnoxaparin1xd">Therapeutic Anticoagulation Treatment with Enoxaparin</a>
               </td>
               <td>
<p>Therapeutic Anticoagulation Treatment (NMH) for non-intensive care hospitalised COVID-19 patients patients with high risk (D-Dimer &gt;= 2mg/l) with Enoxaparin</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="ActivityDefinition-TherapeuticAnticoagulationNMHEnoxaparin2xd.html" title="ActivityDefinition/TherapeuticAnticoagulationNMHEnoxaparin2xd">Therapeutic Anticoagulation Treatment with Enoxaparin</a>
               </td>
               <td>
<p>Therapeutic Anticoagulation Treatment (NMH) for non-intensive care hospitalised COVID-19 patients patients with high risk (D-Dimer &gt;= 2mg/l) with Enoxaparin</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="ActivityDefinition-TherapeuticAnticoagulationFondaparinux.html" title="ActivityDefinition/TherapeuticAnticoagulationFondaparinux">Therapeutic Anticoagulation Treatment with Fondaparinux</a>
               </td>
               <td>
<p>Therapeutic Anticoagulation Treatment with Fondaparinux for non-intensive care hospitalised COVID-19 patients patients with no specific indications (i.e., pulmonary embolism)</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="ActivityDefinition-TherapeuticAnticoagulationNMHNadroparin.html" title="ActivityDefinition/TherapeuticAnticoagulationNMHNadroparin">Therapeutic Anticoagulation Treatment with Nadroparin</a>
               </td>
               <td>
<p>Therapeutic Anticoagulation Treatment (NMH) for non-intensive care hospitalised COVID-19 patientswith high risk (D-Dimer &gt;= 2mg/l) with Nadroparin</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="ActivityDefinition-TherapeuticAnticoagulationNMHTinzaparin.html" title="ActivityDefinition/TherapeuticAnticoagulationNMHTinzaparin">Therapeutic Anticoagulation Treatment with Tinzaparin</a>
               </td>
               <td>
<p>Therapeutic Anticoagulation Treatment (NMH) for non-intensive care hospitalised COVID-19 patients patients with high risk (D-Dimer &gt;= 2mg/l) with Tinzaparin</p>
</td>
            </tr>
         </tbody>
      </table>
   </p>
   <a name="2"> </a>
   <h3>Knowledge Artifacts: Plan Definitions </h3>
   <p>
    <p>These define workflows, rules, strategies, or protocols as part of content in this implementation guide.</p>
</p>
   <p>
      <table class="grid">
         <col style="width:20%"/>
         <tbody>
            <tr>
               <td style="column-width:30%">
                  <a href="PlanDefinition-RecommendationCollectionAbdominalPositioningARDS.html" title="PlanDefinition/RecommendationCollectionAbdominalPositioningARDS">Abdominal positioning for ventilated patients with ARDS and a PaO2/FiO2 &lt; 150 mmHg</a>
               </td>
               <td>
<p>Abdominal positioning for ventilated patients with ARDS and a PaO2/FiO2 &lt; 150 mmHg</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="PlanDefinition-AbdominalPositioningARDSPlan.html" title="PlanDefinition/AbdominalPositioningARDSPlan">Abdominal positioning plan in case of ARDS and a PaO2/FiO2 &lt; 150 mmHg</a>
               </td>
               <td>
<p>In ARDS and a PaO2/FiO2 &lt; 150 mmHg, abdominal positioning should be consistently performed, with an abdominal positioning interval of at least 16 hours.</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="PlanDefinition-NoTherapeuticAnticoagulationICUCOVID19NoIndicationPlan.html" title="PlanDefinition/NoTherapeuticAnticoagulationICUCOVID19NoIndicationPlan">Anticoagulation Plan for hospitalized intensive-care COVID-19 patients with no specific indication</a>
               </td>
               <td>
<p>In intensive care patients without a specific indication (e.g. pulmonary embolism), therapeutic anticoagulation should not be given.</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="PlanDefinition-AntithrombFondapProphInHospitalisedCOVID19PatientsRecommPlan.html" title="PlanDefinition/AntithrombFondapProphInHospitalisedCOVID19PatientsRecommPlan">Antithrombotic prophylaxis with Fondaparinux</a>
               </td>
               <td>
<p>Antithrombotic prophylaxis with Fondaparinux in hospitalised COVID-19 patients</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="PlanDefinition-AntithrombLWMHProphInHospitalisedCOVID19PatientsRecommPlan.html" title="PlanDefinition/AntithrombLWMHProphInHospitalisedCOVID19PatientsRecommPlan">Antithrombotic prophylaxis with LWMH</a>
               </td>
               <td>
<p>Hospitalized patients with COVID-19 should receive standard drug thromboembolism prophylaxis with low molecular weight heparin in the absence of contraindications. Alternatively, fondaparinux may be used.</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="PlanDefinition-RecCollectionNoTherapeuticAnticoagNoIndicationICUCOVID19.html" title="PlanDefinition/RecCollectionNoTherapeuticAnticoagNoIndicationICUCOVID19">No therapeutic anticoagulation for intensive care COVID-19 patients with no specific indication</a>
               </td>
               <td>
<p>No therapeutic anticoagulation for intensive care COVID-19 patients with no specific indication</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="PlanDefinition-VentilatedCOVID19patientsInterventionPlan-fio2-point0.html" title="PlanDefinition/VentilatedCOVID19patientsInterventionPlan-fio2-point0">PEEP Intervention Plan for Population: Ventilated COVID-19 Patients, inspiratory oxygen fraction currently 0.0</a>
               </td>
               <td>
<p>PEEP Intervention Plan for Ventilated COVID-19 Patients, inspiratory oxygen fraction currently 0.0 - 0.39</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="PlanDefinition-VentilatedCOVID19patientsInterventionPlan-fio2-point4.html" title="PlanDefinition/VentilatedCOVID19patientsInterventionPlan-fio2-point4">PEEP Intervention Plan for Population: Ventilated COVID-19 Patients, inspiratory oxygen fraction currently 0.4</a>
               </td>
               <td>
<p>PEEP Intervention Plan for Ventilated COVID-19 Patients, inspiratory oxygen fraction currently 043 - 0.49</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="PlanDefinition-VentilatedCOVID19patientsInterventionPlan-fio2-point5.html" title="PlanDefinition/VentilatedCOVID19patientsInterventionPlan-fio2-point5">PEEP Intervention Plan for Population: Ventilated COVID-19 Patients, inspiratory oxygen fraction currently 0.5</a>
               </td>
               <td>
<p>PEEP Intervention Plan for Ventilated COVID-19 Patients, inspiratory oxygen fraction currently 0.5 - 0.59</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="PlanDefinition-VentilatedCOVID19patientsInterventionPlan-fio2-point6.html" title="PlanDefinition/VentilatedCOVID19patientsInterventionPlan-fio2-point6">PEEP Intervention Plan for Population: Ventilated COVID-19 Patients, inspiratory oxygen fraction currently 0.6</a>
               </td>
               <td>
<p>PEEP Intervention Plan for Ventilated COVID-19 Patients, inspiratory oxygen fraction currently 0.6 - 0.69</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="PlanDefinition-VentilatedCOVID19patientsInterventionPlan-fio2-point7.html" title="PlanDefinition/VentilatedCOVID19patientsInterventionPlan-fio2-point7">PEEP Intervention Plan for Population: Ventilated COVID-19 Patients, inspiratory oxygen fraction currently 0.7</a>
               </td>
               <td>
<p>PEEP Intervention Plan for Ventilated COVID-19 Patients, inspiratory oxygen fraction currently 0.7 - 0.79</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="PlanDefinition-VentilatedCOVID19patientsInterventionPlan-fio2-point8.html" title="PlanDefinition/VentilatedCOVID19patientsInterventionPlan-fio2-point8">PEEP Intervention Plan for Population: Ventilated COVID-19 Patients, inspiratory oxygen fraction currently 0.8</a>
               </td>
               <td>
<p>PEEP Intervention Plan for Ventilated COVID-19 Patients, inspiratory oxygen fraction currently 0.8 - 0.89</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="PlanDefinition-VentilatedCOVID19patientsInterventionPlan-fio2-point9.html" title="PlanDefinition/VentilatedCOVID19patientsInterventionPlan-fio2-point9">PEEP Intervention Plan for Population: Ventilated COVID-19 Patients, inspiratory oxygen fraction currently 0.9</a>
               </td>
               <td>
<p>PEEP Intervention Plan for Ventilated COVID-19 Patients, inspiratory oxygen fraction currently 0.9 - 0.99</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="PlanDefinition-VentilatedCOVID19patientsInterventionPlan-fio2-1.html" title="PlanDefinition/VentilatedCOVID19patientsInterventionPlan-fio2-1">PEEP Intervention Plan for Population: Ventilated COVID-19 Patients, inspiratory oxygen fraction currently 1.0</a>
               </td>
               <td>
<p>PEEP Intervention Plan for Ventilated COVID-19 Patients, inspiratory oxygen fraction currently 1.0 - 1.09</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="PlanDefinition-RecommendationCollectionVentilatedCOVID19patients.html" title="PlanDefinition/RecommendationCollectionVentilatedCOVID19patients">PEEP for ventilated COVID-19 patients</a>
               </td>
               <td>
<p>PEEP for ventilated COVID-19 patients</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="PlanDefinition-RecCollectionProphAnticoagulationHospitalizedCOVID19Patients.html" title="PlanDefinition/RecCollectionProphAnticoagulationHospitalizedCOVID19Patients">Prophylactic anticoagulation in hospitalized COVID-19 patients</a>
               </td>
               <td>
<p>Prophylactic anticoagulation in hospitalized COVID-19 patients</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="PlanDefinition-TherapeuticAnticoagulationNonICUHighRiskCOVID19PatientsPlan.html" title="PlanDefinition/TherapeuticAnticoagulationNonICUHighRiskCOVID19PatientsPlan">Therapeutic Anticoagulation Plan (hospitalised, non-intensive care, COVID-19 patients with no renal function impairment (eGFR &gt;= 30ml/min))</a>
               </td>
               <td>
<p>In hospitalized, non-intensive care patients with COVID-19 and increased risk (e.g., D-dimers ≥ 2 mg/l), therapeutic anticoagulation can be considered if the risk of bleeding is low. Anticoagulation, preferentially with NMH or UFH, can be considered.</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="PlanDefinition-RecCollectionTherapeuticAnticoagNonICUHighRiskCOVID19Patients.html" title="PlanDefinition/RecCollectionTherapeuticAnticoagNonICUHighRiskCOVID19Patients">Therapeutic anticoagulation in non-intensive care, high-risk COVID-19 patients</a>
               </td>
               <td>
<p>Therapeutic anticoagulation in non-intensive care, high-risk COVID-19 patients</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="PlanDefinition-RecommendationCollectionVentilationCOVID19patientsWithARDS.html" title="PlanDefinition/RecommendationCollectionVentilationCOVID19patientsWithARDS">Tidal volume / end-inspiratory airway pressure for ventilated COVID-19 patients with ARDS</a>
               </td>
               <td>
<p>Tidal volume / end-inspiratory airway pressure for ventilated COVID-19 patients with ARDS</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="PlanDefinition-RecommendationCollectionVentilatedPatientsWithARDS.html" title="PlanDefinition/RecommendationCollectionVentilatedPatientsWithARDS">Tidal volume for ventilated patients with ARDS</a>
               </td>
               <td>
<p>Tidal volume for ventilated patients with ARDS</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="PlanDefinition-VentilatedCOVID19PatientsWithARDSVentilationPlan.html" title="PlanDefinition/VentilatedCOVID19PatientsWithARDSVentilationPlan">Ventilation Plan for COVID-19 patients with ARDS</a>
               </td>
               <td>
<p>In ventilated patients with COVID-19 and ARDS, tidal volume should be ≤ 6 ml/kg standard body weight, end-inspiratory airway pressure ≤ 30 cm H2O.</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="PlanDefinition-VentilatedARDSPatientsInterventionPlan.html" title="PlanDefinition/VentilatedARDSPatientsInterventionPlan">Ventilation Plan for patients with ARDS</a>
               </td>
               <td>
<p>We recommend ventilating patients with ARDS with a VT ≤ 6 ml/kg standard body weight (bw). (Table 1, Appendix)</p>
</td>
            </tr>
         </tbody>
      </table>
   </p>
   <a name="3"> </a>
   <h3>Terminology: Code Systems </h3>
   <p>
    <p>These define new code systems used by systems conforming to this implementation guide.</p>
</p>
   <p>
      <table class="grid">
         <col style="width:20%"/>
         <tbody>
            <tr>
               <td style="column-width:30%">
                  <a href="CodeSystem-codex-celida.html" title="CodeSystem/codex-celida">CODEX-CELIDA</a>
               </td>
               <td>
<p>Concepts required in recommendations that are not defined elsewhere</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="CodeSystem-KontaktArtDe.html" title="CodeSystem/KontaktArtDe">KontaktArtDe</a>
               </td>
               <td>
<p>Klassifizierung eines Kontaktes mit einer Gesundheitseinrichtung</p>
</td>
            </tr>
         </tbody>
      </table>
   </p>
   <a name="4"> </a>
   <h3>Other </h3>
   <p>
    <p>These are resources that are used within this implementation guide that do not fit into one of the other categories.</p>
</p>
   <p>
      <table class="grid">
         <col style="width:20%"/>
         <tbody>
            <tr>
               <td style="column-width:30%">
                  <a href="EvidenceVariable-PopHospitalisedICUCOVID19Patients.html" title="EvidenceVariable/PopHospitalisedICUCOVID19Patients">Hospitalised COVID-19 patients, treated on ICU, without thrombembolic complication</a>
               </td>
               <td>
<p>Hospitalised COVID-19 patients, treated on ICU, without thrombembolic complication</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="EvidenceVariable-PopHospitalisedCOVID19PatientsWithContraIndications.html" title="EvidenceVariable/PopHospitalisedCOVID19PatientsWithContraIndications">Population: Hospitalised COVID-19 patients with existing contraindications to LWMH</a>
               </td>
               <td>
<p>Population for recommendation 15: Hospitalised COVID-19 patients with existing contraindications to LWMH</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="EvidenceVariable-PopHospitalisedCOVID19PatientsWOContraIndications.html" title="EvidenceVariable/PopHospitalisedCOVID19PatientsWOContraIndications">Population: Hospitalised COVID-19 patients without contraindications to LWMH</a>
               </td>
               <td>
<p>Population for recommendation 15: Hospitalised COVID-19 patients without contraindications to LWMH</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="EvidenceVariable-PopHospitalisedNonICUCOVID19PatientsWITHHighRisk.html" title="EvidenceVariable/PopHospitalisedNonICUCOVID19PatientsWITHHighRisk">Population: Hospitalised COVID-19 patients without the need for intensive care therapy considered high-risk for developing venous thrombosis</a>
               </td>
               <td>
<p>Population for recommendation 17 from guideline from https://www.awmf.org/leitlinien/detail/ll/113-001LG.html with characteristics: without the need for intensive care therapy, considered high-risk for developing venous thrombosis</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="EvidenceVariable-PopulationVentilatedCOVID19patientsWithARDS.html" title="EvidenceVariable/PopulationVentilatedCOVID19patientsWithARDS">Population: Ventilated COVID-19 Patients with ARDS</a>
               </td>
               <td>
<p>Ventilated COVID-19 patients with ARDS</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="EvidenceVariable-PopVentilatedCOVID19patientsWithARDSWithOxygenationFailure.html" title="EvidenceVariable/PopVentilatedCOVID19patientsWithARDSWithOxygenationFailure">Population: Ventilated COVID-19 Patients with severe ARDS</a>
               </td>
               <td>
<p>Ventilated COVID-19 patients with severe ARDS, defined by oxygenation failure (Horovitz Quotient lower than 150)</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="EvidenceVariable-PopulationVentilatedCOVID19patients-fio2-point0.html" title="EvidenceVariable/PopulationVentilatedCOVID19patients-fio2-point0">Population: Ventilated COVID-19 Patients, inspiratory oxygen fraction currently 0.0</a>
               </td>
               <td>
<p>Ventilated COVID-19 patients, inspiratory oxygen fraction currently 0.0 - 0.39</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="EvidenceVariable-PopulationVentilatedCOVID19patients-fio2-point4.html" title="EvidenceVariable/PopulationVentilatedCOVID19patients-fio2-point4">Population: Ventilated COVID-19 Patients, inspiratory oxygen fraction currently 0.4</a>
               </td>
               <td>
<p>Ventilated COVID-19 patients, inspiratory oxygen fraction currently 0.4 - 0.49</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="EvidenceVariable-PopulationVentilatedCOVID19patients-fio2-point5.html" title="EvidenceVariable/PopulationVentilatedCOVID19patients-fio2-point5">Population: Ventilated COVID-19 Patients, inspiratory oxygen fraction currently 0.5</a>
               </td>
               <td>
<p>Ventilated COVID-19 patients, inspiratory oxygen fraction currently 0.5 - 0.59</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="EvidenceVariable-PopulationVentilatedCOVID19patients-fio2-point6.html" title="EvidenceVariable/PopulationVentilatedCOVID19patients-fio2-point6">Population: Ventilated COVID-19 Patients, inspiratory oxygen fraction currently 0.6</a>
               </td>
               <td>
<p>Ventilated COVID-19 patients, inspiratory oxygen fraction currently 0.6 - 0.69</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="EvidenceVariable-PopulationVentilatedCOVID19patients-fio2-point7.html" title="EvidenceVariable/PopulationVentilatedCOVID19patients-fio2-point7">Population: Ventilated COVID-19 Patients, inspiratory oxygen fraction currently 0.7</a>
               </td>
               <td>
<p>Ventilated COVID-19 patients, inspiratory oxygen fraction currently 0.7 - 0.79</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="EvidenceVariable-PopulationVentilatedCOVID19patients-fio2-point8.html" title="EvidenceVariable/PopulationVentilatedCOVID19patients-fio2-point8">Population: Ventilated COVID-19 Patients, inspiratory oxygen fraction currently 0.8</a>
               </td>
               <td>
<p>Ventilated COVID-19 patients, inspiratory oxygen fraction currently 0.8 - 0.89</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="EvidenceVariable-PopulationVentilatedCOVID19patients-fio2-point9.html" title="EvidenceVariable/PopulationVentilatedCOVID19patients-fio2-point9">Population: Ventilated COVID-19 Patients, inspiratory oxygen fraction currently 0.9</a>
               </td>
               <td>
<p>Ventilated COVID-19 patients, inspiratory oxygen fraction currently 0.9 - 0.99</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="EvidenceVariable-PopulationVentilatedCOVID19patients-fio2-1.html" title="EvidenceVariable/PopulationVentilatedCOVID19patients-fio2-1">Population: Ventilated COVID-19 Patients, inspiratory oxygen fraction currently 1.0</a>
               </td>
               <td>
<p>Ventilated COVID-19 patients, inspiratory oxygen fraction currently 1.0</p>
</td>
            </tr>
            <tr>
               <td style="column-width:30%">
                  <a href="EvidenceVariable-PopulationVentilatedARDSPatients.html" title="EvidenceVariable/PopulationVentilatedARDSPatients">Population: Ventilated patients with ARDS</a>
               </td>
               <td>
<p>Patients with ARDS</p>
</td>
            </tr>
         </tbody>
      </table>
   </p>
</div>

</div>
        </div>    <!-- /inner-wrapper -->
      </div>    <!-- /row -->
    </div>    <!-- /container -->
  </div>    <!-- /segment-content -->

  <script src="assets/js/jquery.js" type="text/javascript"> </script>       <!-- note keep space here, otherwise it will be transformed to empty tag -> fails -->
  <script src="assets/js/jquery-ui.min.js" type="text/javascript"> </script>

  <script type="text/javascript">
    $(document).ready(function(){
      if(window.location.hash != "") {
          $('a[href="' + window.location.hash + '"]').click()
      }
    });
  </script>
  <div igtool="footer" id="segment-footer" class="segment">    <!-- segment-footer -->
    <div class="container">    <!-- container -->
      <div class="inner-wrapper">
        <p>
          IG &copy; 2021+ <a href="https://www.medizin.uni-greifswald.de/">Universitätsmedizin Greifswald</a>.  Package recommendations.celida.codex.netzwerk-universitaetsmedizin.de#1.5.2 based on <a href="http://hl7.org/fhir/R5/">FHIR 5.0.0</a>. Generated <span title="Wed, Aug 7, 2024 14:55+0000">2024-08-07</span>
          <br/>
          <span style="color: #FFFF77">
            <p style="color: white"><a name="l1468">​</a>
       Links: <a href="toc.html">Table of Contents</a> |
       <a href="qa.html">QA Report</a> |
       <a href="https://github.com/CODEX-CELIDA/recommendations.celida.codex.netzwerk-universitaetsmedizin.de/issues/" target="_blank">Issues</a> |
       <a href="https://github.com/CODEX-CELIDA/recommendations.celida.codex.netzwerk-universitaetsmedizin.de/issues/new" target="_blank">Submit an issue</a> |
       <a href="http://hl7.org/fhir/R5//history.html" target="_blank">Version History</a> |
       <a rel="license" href="http://hl7.org/fhir/R5/license.html"><img src="assets/images/cc-by.svg" alt="CC-BY" style="border-style: none;" height="17"/></a> |
</p>

<script src="assets/js/imageMapResizer.min.js" type="text/javascript"></script>
<script type="text/javascript">
       imageMapResize();
</script>

          </span>
        </p>
      </div>    <!-- /inner-wrapper -->
    </div>    <!-- /container -->
  </div>    <!-- /segment-footer -->

  <div id="segment-post-footer" class="segment hidden">    <!-- segment-post-footer -->
    <div class="container">    <!-- container -->
    </div>    <!-- /container -->
  </div>    <!-- /segment-post-footer -->

    <!-- JS and analytics only. -->
    <!-- Bootstrap core JavaScript -->

    <!-- Placed at the end of the document so the pages load faster -->
  <script src="assets/js/bootstrap.min.js" type="text/javascript"> </script>
  <script src="assets/js/respond.min.js" type="text/javascript"> </script>
  <script src="assets/js/anchor.min.js" type="text/javascript"> </script>
  <script>anchors.options.visible = 'hover'
anchors.add()</script>

    <!-- feedback form - Google forms -->
  <!-- v0.1, 2021-01-09 -->



  <!-- / feedback form -->

    <!-- Analytics Below
  ================================================== -->
  </body>
</html>